We are live on
!
Find out more
CCM
Courage Capital Management Portfolio holdings
AUM
$70.6M
1-Year Est. Return
13.29%
This Fund
S&P 500
This Quarter
Est. Return
+7.97%
1 Year Est. Return
+13.29%
3 Year Est. Return
+76.1%
5 Year Est. Return
+95.09%
10 Year Est. Return
+7,780.05%
AUM
$24.8M
AUM Growth
-$4.71M
(-16%)
Cap. Flow
-$14.6M
Cap. Flow
% of AUM
-58.75%
Top 10 Holdings %
Top 10 Hldgs %
98.74%
Holding
12
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$326K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coherus Oncology
CHRS
|
+$187K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 15.99% |
| 2 | Healthcare | 7.55% |
| 3 | Real Estate | 5.58% |
| 4 | Industrials | 1.26% |
Similar funds
FCI
HB
YEPX
DWRES
AC
PWS
WH
FWA
Courage Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Courage Capital Management held 12 positions worth $24.8M, down 16% from $29.5M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Courage Capital Management withdrew a net $14.6M in Q4 2023, closing 1 position. Its most notable exit was Coherus Oncology, an estimated $187K position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 16% of assets, up from 11% a quarter earlier, followed by Healthcare and Real Estate.
Against the trend, Courage Capital Management added an estimated $326K to Meta Platforms (Facebook).
- Courage Capital Management added most to Meta Platforms (Facebook) in Q4 2023, an estimated $326K increase.
- Courage Capital Management fully exited Coherus Oncology in Q4 2023, selling an estimated $187K.
- Courage Capital Management's ten largest holdings make up 99% of its $24.8M portfolio in Q4 2023.
- Courage Capital Management opened 0 new positions and closed 1 in Q4 2023.
- Courage Capital Management's portfolio value fell 16% quarter-over-quarter to $24.8M.
Based on Courage Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.